These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19020722)

  • 1. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
    Noske A; Lindenberg JL; Darb-Esfahani S; Weichert W; Buckendahl AC; Röske A; Sehouli J; Dietel M; Denkert C
    Oncol Rep; 2008 Dec; 20(6):1409-17. PubMed ID: 19020722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
    Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effeet of rapamycin on mTOR and eIF-4E expression in coxsackievirus B3-induced rat myocardial cells].
    Chen CY; Sun YN; Yang ZC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):612-7. PubMed ID: 18667775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
    Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
    Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.
    Ruggero D; Montanaro L; Ma L; Xu W; Londei P; Cordon-Cardo C; Pandolfi PP
    Nat Med; 2004 May; 10(5):484-6. PubMed ID: 15098029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
    BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
    Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
    Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
    Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy.
    Faried LS; Faried A; Kanuma T; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
    Oncol Rep; 2006 Jul; 16(1):57-63. PubMed ID: 16786123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
    Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.
    Righi L; Volante M; Rapa I; Tavaglione V; Inzani F; Pelosi G; Papotti M
    Endocr Relat Cancer; 2010 Dec; 17(4):977-87. PubMed ID: 20817788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
    Brown RE; Zhang PL; Lun M; Zhu S; Pellitteri PK; Riefkohl W; Law A; Wood GC; Kennedy TL
    Ann Clin Lab Sci; 2006; 36(3):273-82. PubMed ID: 16951268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
    Anagnostou VK; Bepler G; Syrigos KN; Tanoue L; Gettinger S; Homer RJ; Boffa D; Detterbeck F; Rimm DL
    Clin Cancer Res; 2009 Jun; 15(12):4157-64. PubMed ID: 19509151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
    Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
    Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism.
    Greenberg VL; Zimmer SG
    Oncogene; 2005 Jul; 24(30):4851-60. PubMed ID: 15897904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
    Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
    Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation.
    Sieghart W; Fuereder T; Schmid K; Cejka D; Werzowa J; Wrba F; Wang X; Gruber D; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Wacheck V
    Transplantation; 2007 Feb; 83(4):425-32. PubMed ID: 17318075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics.
    Buckendahl AC; Budczies J; Fiehn O; Darb-Esfahani S; Kind T; Noske A; Weichert W; Sehouli J; Braicu E; Dietel M; Denkert C
    Oncol Rep; 2011 Apr; 25(4):1005-12. PubMed ID: 21271224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
    Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
    J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.